Literature DB >> 23897615

In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.

Kevin M D'Auria1, Glynis L Kolling, Gina M Donato, Cirle A Warren, Mary C Gray, Erik L Hewlett, Jason A Papin.   

Abstract

Toxin A (TcdA) and toxin B (TcdB) of Clostridium difficile cause gross pathological changes (e.g., inflammation, secretion, and diarrhea) in the infected host, yet the molecular and cellular pathways leading to observed host responses are poorly understood. To address this gap, we evaluated the effects of single doses of TcdA and/or TcdB injected into the ceca of mice, and several endpoints were analyzed, including tissue pathology, neutrophil infiltration, epithelial-layer gene expression, chemokine levels, and blood cell counts, 2, 6, and 16 h after injection. In addition to confirming TcdA's gross pathological effects, we found that both TcdA and TcdB resulted in neutrophil infiltration. Bioinformatics analyses identified altered expression of genes associated with the metabolism of lipids, fatty acids, and detoxification; small GTPase activity; and immune function and inflammation. Further analysis revealed transient expression of several chemokines (e.g., Cxcl1 and Cxcl2). Antibody neutralization of CXCL1 and CXCL2 did not affect TcdA-induced local pathology or neutrophil infiltration, but it did decrease the peripheral blood neutrophil count. Additionally, low serum levels of CXCL1 and CXCL2 corresponded with greater survival. Although TcdA induced more pronounced transcriptional changes than TcdB and the upregulated chemokine expression was unique to TcdA, the overall transcriptional responses to TcdA and TcdB were strongly correlated, supporting differences primarily in timing and potency rather than differences in the type of intracellular host response. In addition, the transcriptional data revealed novel toxin effects (e.g., altered expression of GTPase-associated and metabolic genes) underlying observed physiological responses to C. difficile toxins.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23897615      PMCID: PMC3811747          DOI: 10.1128/IAI.00869-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.

Authors:  C Pothoulakis; R J Gilbert; C Cladaras; I Castagliuolo; G Semenza; Y Hitti; J S Montcrief; J Linevsky; C P Kelly; S Nikulasson; H P Desai; T D Wilkins; J T LaMont
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

3.  Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.

Authors:  E Chaves-Olarte; M Weidmann; C Eichel-Streiber; M Thelestam
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.

Authors:  C Pothoulakis; U Galili; I Castagliuolo; C P Kelly; S Nikulasson; P K Dudeja; T A Brasitus; J T LaMont
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

Review 5.  Toxin A-negative, toxin B-positive Clostridium difficile.

Authors:  Denise Drudy; Séamus Fanning; Lorraine Kyne
Journal:  Int J Infect Dis       Date:  2006-07-20       Impact factor: 3.623

6.  Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB.

Authors:  Ralf Gerhard; Helma Tatge; Harald Genth; Thomas Thum; Jürgen Borlak; Gerhard Fritz; Ingo Just
Journal:  J Biol Chem       Date:  2004-11-05       Impact factor: 5.157

7.  Angiotensin II subtype 1 receptor blockade inhibits Clostridium difficile toxin A-induced intestinal secretion in a rabbit model.

Authors:  Cirle S Alcantara; Xiao-Hong Jin; Gerly Anne C Brito; Benedito A Carneiro-Filho; Leah J Barrett; Robert M Carey; Richard L Guerrant
Journal:  J Infect Dis       Date:  2005-05-03       Impact factor: 5.226

8.  Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding.

Authors:  R D Rolfe; W Song
Journal:  J Med Microbiol       Date:  1995-01       Impact factor: 2.472

9.  Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells.

Authors:  I Castagliuolo; A C Keates; C C Wang; A Pasha; L Valenick; C P Kelly; S T Nikulasson; J T LaMont; C Pothoulakis
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

10.  Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.

Authors:  C P Kelly; S Becker; J K Linevsky; M A Joshi; J C O'Keane; B F Dickey; J T LaMont; C Pothoulakis
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  21 in total

1.  Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

Authors:  Mizuho Hasegawa; Shoko Yada; Meng Zhen Liu; Nobuhiko Kamada; Raúl Muñoz-Planillo; Nhu Do; Gabriel Núñez; Naohiro Inohara
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.

Authors:  Edward van Opstal; Glynis L Kolling; John H Moore; Christine M Coquery; Nekeithia S Wade; William M Loo; David T Bolick; Jae Hyun Shin; Loren D Erickson; Cirle A Warren
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

3.  Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.

Authors:  Carrie A Cowardin; Brianna M Jackman; Zannatun Noor; Stacey L Burgess; Andrew L Feig; William A Petri
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

Review 4.  Antibodies for treatment of Clostridium difficile infection.

Authors:  David P Humphreys; Mark H Wilcox
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

5.  The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.

Authors:  Yongrong Zhang; Zhiyong Yang; Si Gao; Therwa Hamza; Harris G Yfantis; Michael Lipsky; Hanping Feng
Journal:  Anaerobe       Date:  2017-10-12       Impact factor: 3.331

6.  Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.

Authors:  Zhiyong Yang; Yongrong Zhang; Tuxiong Huang; Hanping Feng
Journal:  Gut Microbes       Date:  2015-06-19

7.  Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea.

Authors:  David T Bolick; Glynis L Kolling; John H Moore; Luís Antônio de Oliveira; Kenneth Tung; Casandra Philipson; Monica Viladomiu; Raquel Hontecillas; Josep Bassaganya-Riera; Richard L Guerrant
Journal:  Gut Microbes       Date:  2014

Review 8.  Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.

Authors:  Yongrong Zhang; Hanping Feng
Journal:  Pathog Dis       Date:  2016-04-04       Impact factor: 3.166

9.  Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host.

Authors:  Jae Hyun Shin; Yingnan Gao; John H Moore; David T Bolick; Glynis L Kolling; Martin Wu; Cirle A Warren
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

Review 10.  Host recognition of Clostridium difficile and the innate immune response.

Authors:  Carrie A Cowardin; William A Petri
Journal:  Anaerobe       Date:  2014-09-16       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.